{"id":"https://genegraph.clinicalgenome.org/r/d531b98a-2445-4ac8-9a37-634ea1f8833bv1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between *COX8A* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of March 18, 2024. The *COX8A* gene encodes cytochrome *c* oxidase (complex IV) subunit 8A. Defects of this protein lead to complex IV deficiency.\n\nThe first and only case report of *COX8A*-related autosomal recessive primary mitochondrial disease was in 2016 (PMID: 26685157), in an individual from a consanguineous family with Leigh syndrome spectrum (LSS) disorder, congenital scoliosis, developmental delay, pulmonary hypertension, epilepsy, and lactic acidosis. While various names have been given to the constellation of features seen in those with *COX8A*-related disorders, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the COX8A phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Of note, *COX8A* was first curated by this Expert Panel for its association with LSS on June 8, 2020 (SOP V7), with a final classification of Limited. This current curation for the association with primary mitochondrial disease includes the single case included in the LSS curation.\n\nEvidence supporting this gene-disease relationship includes case-level data and experimental data. This included one intronic variant impacting splicing (PMID: 26685157) in the single reported proband.\n\nThe mechanism of disease is loss of function. This gene-disease association is also supported by the known biochemical function of COX8A as a subunit of complex IV, as well as functional alteration in non-patient cells (PMID: 33705280) and rescue in patient cells (PMID: 26685157).\n\nIn summary, there is limited evidence to support this gene-disease relationship given that only one case has been reported to date. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on March 18, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d531b98a-2445-4ac8-9a37-634ea1f8833b","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a1671723-9b23-4f70-b64d-dd1829b926bc","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a1671723-9b23-4f70-b64d-dd1829b926bc_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2025-01-14T18:02:03.235Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/a1671723-9b23-4f70-b64d-dd1829b926bc_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2024-03-18T04:00:00.000Z","role":"Approver"}],"curationReasonDescription":"This classification was kept at limited given only a single case has been reported to date. Of note, this case does have compelling functional support for primary mitochondrial disease.","curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1671723-9b23-4f70-b64d-dd1829b926bc_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1671723-9b23-4f70-b64d-dd1829b926bc_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be9dd136-fbc7-4650-b0cf-5185f1cdded2","type":"EvidenceLine","dc:description":"Score 0.5 points for rescue of respiratory activity and 0.5 points for subunit immunoreactivity data","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59951f36-a205-4e00-bd25-5ab59425c9c8","type":"Finding","dc:description":"Opposite to the sample transfected with the empty virus (Fig. 4D), in the COX8A-transduced sample, a high proportion of fibroblasts showed a typical mitochondrial pattern of MT-CO1 immunoreactivity (Fig. 4G), and this co-localized with the NDUFS5 (complex I) signal (Fig. 4H).\n\nIn functional activity assays on fibroblast homogenates, viral expression of COX8A caused a substantial increase of COX activity reaching almost 67% of the control activity and correlated with the percentage of transduced cells and the percentage of MT-CO1 immunoreactive cells (Fig. 4B).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26685157","rdfs:label":"Lentiviral rescue in patient fibroblasts","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a1671723-9b23-4f70-b64d-dd1829b926bc_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bdcd297b-d6b0-4c8b-9b25-6d25e25e7e69","type":"EvidenceLine","dc:description":"Score 0.5 points for COX deficiency\nScore 0.5 points for reduction in complex IV subunits by immunoblot (COX1, COX5A), and reduction (only trace amount of COX monomer and dimer forms)\n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bf00e7f-25a0-4cb0-a921-5a391206fd1b","type":"FunctionalAlteration","dc:description":"COX activity was 13% for one clone and 12% for second clone when normalized to CS \n\nScore 0.5 points for reduction in complex IV subunits by immunoblot (COX1, COX5A), and reduction (only trace amount of COX monomer and dimer forms)\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33705280","rdfs:label":"HEK293T Cells with COX deficiency"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a1671723-9b23-4f70-b64d-dd1829b926bc_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/024c5e24-766f-4038-802e-eb7466d65d97","type":"EvidenceLine","dc:description":">10 genes involved in complex IV assembly associated with primary mitochondrial disease","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2fb04c7e-3fcb-4c98-b81b-ec90d6e6d694","type":"Finding","dc:description":"All genes are either complex IV subunits or assembly factors associated with mitochondrial disease ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30030519","rdfs:label":"Numerous Complex IV Subunits and Assembly Factors ","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/a1671723-9b23-4f70-b64d-dd1829b926bc_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03096d9e-af0b-43ad-a905-ef36c07936a3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6706a01-eb93-4ab0-8115-28ee57d286ae","type":"EvidenceLine","dc:description":"Score at default 1 pt for loss of function (small protein, may escape NMD), + 0.2 (uniformly weak COX staining + COX deficiency in muscle 10% of control) + 0.2 (COX deficiency in fibros 5% of control)","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6706a01-eb93-4ab0-8115-28ee57d286ae_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"A shorter COX8A-specific PCR product was present in fibroblasts of the COX8A patient (Fig. 3B, asterisk), indicating aberrant splicing - this 49 nt  deletion results in a shift of the reading frame for the entire exon 2 (Fig. 3C). As exon 2 encodes the 31 C-terminal amino acids of the 44 amino acid-long mature peptide, the translated mutant protein is very likely not functional. \n lack of normal COX8A transcript in the patientâ€™s sample,","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b6706a01-eb93-4ab0-8115-28ee57d286ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26685157","allele":{"id":"https://genegraph.clinicalgenome.org/r/0e4516f2-f9ce-449e-a1ef-366eb886a16f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004074.3(COX8A):c.115-1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA352165"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/03096d9e-af0b-43ad-a905-ef36c07936a3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26685157","rdfs:label":"Hallman et al 2016 Proband ","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0e4516f2-f9ce-449e-a1ef-366eb886a16f"},"detectionMethod":"COX8A homoyzgous for c.115-1G>C\n\nAbsent in gnomADv4.0.0","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0007146","obo:HP_0001263","obo:HP_0004322","obo:HP_0001252","obo:HP_0000252","obo:HP_0002092","obo:HP_0003128","obo:HP_0034353","obo:HP_0008453","obo:HP_0002151","obo:HP_0001250"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b6706a01-eb93-4ab0-8115-28ee57d286ae_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Limited","sequence":9807,"specifiedBy":"GeneValidityCriteria10","strengthScore":7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/fQ6J_RYWyQA","type":"GeneValidityProposition","disease":"obo:MONDO_0044970","gene":"hgnc:2294","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a1671723-9b23-4f70-b64d-dd1829b926bc-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}